In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma

BACKGROUND: In patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), virus-specific cytotoxic T lymphocytes (CTLs) fail to eliminate HCC cells expressing HBV antigens. As the expression of viral antigen in HBV-associated HCC may decrease to allow tumor to escape immune attack...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Liu, Qi, Tian, Ye, Li, Yanyan, Zhang, Wei, Cai, Wenxuan, Liu, Yaju, Ren, Yuefei, Liang, Zhaoduan, Zhou, Peipei, Zhang, Yajing, Bao, Yifeng, Li, Yi
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020
Fag:
Immune Cell Therapies and Immune Cell Engineering
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7745518/
https://ncbi.nlm.nih.gov/pubmed/33323464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001748
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker